120 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
, warranties or representations of any kind, written or oral, express or implied, including any relating to the nature of the position or its duration … opportunity to review this arbitration provision, inquire about the nature and extent of the costs of arbitration and seek legal advice.
Initial Here: NJ
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification … or such enforcement or setoff had not occurred.
5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any
8-K
EX-10.2
vzxkfby
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.2
exc6 bjnv51b50a
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
t2m9mexz7k2typj
12 Dec 22
Changes in Registrant's Certifying Accountant
8:14pm
D
zsg50tjse kwozl2
5 Dec 22
$6.00 mm in equity / options, sold $6.00 mm, 2 investors
7:25pm
8-K
EX-10.1
0sx67iwz
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.2
qq2kvvon8qx3hlt6fw3
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
424B3
vmsc29hdlv3taa
19 Oct 22
Prospectus supplement
6:10am